Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.

Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Abstract Text:

    hitoshi kimuraHitoshi Kimura,hiroyuki katoHiroyuki Kato,naritaka tanakaNaritaka Tanaka,takanori inoseTakanori Inose,ahmad fariedAhmad Faried,makoto sohdaMakoto Sohda,masanobu nakajimaMasanobu Nakajima,yasuyuki fukaiYasuyuki Fukai,tatsuya miyazakiTatsuya Miyazaki,norihiro masudaNorihiro Masuda,ryokuhei mandaRyokuhei Manda,minoru fukuchiMinoru Fukuchi,hitoshi ojimaHitoshi Ojima,katsuhiko tsukadaKatsuhiko Tsukada,hiroyuki kuwanoHiroyuki Kuwano,

    BACKGROUND: Circulating vascular endothelial growth factor-C (VEGF-C) levels were measured in patients with esophageal cancer to assess the value of VEGF-C as a biomarker for predicting tumor recurrence. PATIENTS AND METHODS: Preoperative serum samples were acquired from 80 patients and healthy volunteers who served as normal controls. VEGF-C levels were assessed using enzyme-linked immunosorbent assay (ELISA). RESULTS: The preoperative serum VEGF-C level in patients with esophageal cancer was significantly higher than in healthy volunteers. Furthermore, patients with recurrence had significantly higher preoperative serum VEGF-C levels than patients without recurrence, and a high preoperative serum VEGF-C level was found to be an independent risk factor for recurrence, in addition to lymph node metastasis. CONCLUSION: Preoperative VEGF-C levels may reflect malignancy, such as lymph node metastasis, and predict recurrence in patients with esophageal cancer. Therefore, the preoperative VEGF-C level may be a useful biomarker for choice of multimodality therapy.

    Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Publishing Authors By Initials

    h kimuraH Kimura,h katoH Kato,n tanakaN Tanaka,t inoseT Inose,a fariedA Faried,m sohdaM Sohda,m nakajimaM Nakajima,y fukaiY Fukai,t miyazakiT Miyazaki,n masudaN Masuda,r mandaR Manda,m fukuchiM Fukuchi,h ojimaH Ojima,k tsukadaK Tsukada,h kuwanoH Kuwano,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Anticancer research

    VOLUME: 28

    Page Numbers: 165-9

    Journal Abbreviation:

    ISSN: 0250-7005

    DAY: 3

    MONTH: 04

    YEAR: 2008

    Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8102988

    Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.

    AFFILIATION: Department of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, 371-8511, Japan. hkimura@med.gunma-u.ac.jp

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Anticancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Preoperative serum vascular endothelial growth factor-C VEGF-C levels predict recurrence in patients with esophageal cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News